Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
Abstract Introduction Limited access to healthcare during the COVID-19 pandemic prompted patients to seek care using telehealth. In this study, we assessed whether treatment patterns differed for patients with psoriasis (PsO) or psoriatic arthritis (PsA) initiating apremilast by either a telehealth...
Saved in:
Main Authors: | Ashis K. Das (Author), Eunice Chang (Author), Caleb Paydar (Author), Michael S. Broder (Author), Kate K. Orroth (Author), Myriam Cordey (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
by: Ashis K. Das, et al.
Published: (2023) -
Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world settingCapsule Summary
by: Cristi Cavanaugh, MHS, et al.
Published: (2024) -
Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
by: Forchhammer S, et al.
Published: (2015) -
New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast
by: Palfreeman AC, et al.
Published: (2013) -
[Translated article] Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis
by: P. Garbayo Salmons, et al.
Published: (2022)